Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next...
Pharmaceutical Technology via Yahoo Finance· 1 day agoSouth Africa’s existing regulatory, consent and ethics frameworks around HIV vaccine trial investigations helped with regards to quick initiation and straightforward progress ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 6 days agoLast year, Novavax lost $5.41 per share and had $983.7 million in sales. This year, Wall Street...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 6 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 5 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
FDA advises Covid vaccine makers to target new contagious strain for fall shots
NBC Universal via AOL· 6 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 6 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Center for Infectious Disease Research and Policy· 5 days agoShortly after, the FDA accepted the advisers' advice but said it would continue to monitor the...
Is It Too Late to Buy Novavax Stock? | The Motley Fool
The Motley Fool· 6 days agoNovavax (NVAX -4.32%) stock is suddenly a buy again this year, with its stock price more than...